Drug Profile
SA 1042
Latest Information Update: 12 Jun 2001
Price :
$50
*
At a glance
- Originator Sankyo
- Class Antivirals
- Mechanism of Action HIV envelope protein gp120 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 12 Jun 2001 No-Development-Reported for HIV infections treatment in Japan (Unknown route)
- 10 Sep 1998 Profile reviewed but no significant changes made
- 30 Jul 1996 New profile